Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.21.2
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
3 Months Ended
Jul. 31, 2021
$ / shares
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Exercise price (in dollars per share) $ 0.0004
Equity Option [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Number of stock excluded | shares 7,250,000
Exercise price (in dollars per share) $ 0.0004